REVIEW article
Front. Nutr.
Sec. Nutrition and Metabolism
Targeting colorectal cancer with hesperidin and hesperetin: A comprehensive review of antiproliferative activity, chemopreventive, anti-inflammatory, and antioxidant effects
Provisionally accepted
- Department of Pathology, Hangzhou Xixi Hospital, Hangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Colorectal cancer (CRC) residues one of the leading reasons of cancer-related mortality worldwide, with increasing incidence attributed to dietary, environmental, and genetic factors. Despite advances in conventional therapies, including chemotherapy and targeted agents, treatment resistance and adverse side effects highlight the need for novel, safer, and more effective therapeutic strategies. Hesperidin (HSD) and hesperetin (HST), bioflavonoid abundantly found in citrus fruits, has emerged as a promising candidate due to its wide-ranging biological activities, particularly its role in modulating key molecular pathways involved in carcinogenesis. This comprehensive review explores the multifaceted anticancer potential of HSD and HST in the context of CRC, focusing on its ability to control programmed cell death mechanisms like autophagy and apoptosis, suppress chronic inflammation, and counteract oxidative stress—three pivotal hallmarks of tumor initiation and progression. Additionally, we examine the synergistic effects of HSD and HST with standard chemotherapeutic agents and its potential as a chemopreventive or adjuvant therapeutic compound. By consolidating preclinical and emerging clinical evidence, this review highlights the translational value of HSD and HST in CRC prevention and management. Understanding its molecular underpinnings may pave the way for HSD-and HST-based nutraceuticals and targeted therapies, contributing to a more personalized and integrative approach to CRC treatment.
Keywords: colorectal cancer, Hesperidin, Apoptotic, anti-inflammatory, antioxidant
Received: 16 Jun 2025; Accepted: 31 Oct 2025.
Copyright: © 2025 Su. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yu Su, suyu88195@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.